Live·Open questions in longevity research
Back to Eternal Search
Omri Amirav-Drory

Omri Amirav-Drory

vc
Fund operatorEcosystem influencer

About

Omri Amirav-Drory, Ph.D., is General Partner and Head of NFX Bio, where he backs early-stage techbio companies. He previously founded Genome Compiler, which was acquired by Twist Bioscience, and later served in corporate development at Twist. He is also the founding CEO/partner behind Tech.Bio and serves on boards including ImmuneBridge.

Areas of interest

biotechtechbiosynthetic biologydrug discoverygenerative AIlongevityscientist-foundersbioeconomy